HCV CURE LEADS TO IMPROVEMENTS IN TYPE 2 DIABETES
Conferences
Wyatt, B; Abraham, SV; Dinani, A; Mageras, A; Miller, M; Harty, AL; Perumalswami, PV; Vandromme, M; Branch, AD
Published in: HEPATOLOGY
November 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
November 2020
Volume
72
Start / End Page
559A / 559A
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wyatt, B., Abraham, S. V., Dinani, A., Mageras, A., Miller, M., Harty, A. L., … Branch, A. D. (2020). HCV CURE LEADS TO IMPROVEMENTS IN TYPE 2 DIABETES. In HEPATOLOGY (Vol. 72, pp. 559A-559A).
Wyatt, Brooke, Sherley V. Abraham, Amreen Dinani, Anna Mageras, Mark Miller, Alyson L. Harty, Ponni V. Perumalswami, Maxence Vandromme, and Andrea D. Branch. “HCV CURE LEADS TO IMPROVEMENTS IN TYPE 2 DIABETES.” In HEPATOLOGY, 72:559A-559A, 2020.
Wyatt B, Abraham SV, Dinani A, Mageras A, Miller M, Harty AL, et al. HCV CURE LEADS TO IMPROVEMENTS IN TYPE 2 DIABETES. In: HEPATOLOGY. 2020. p. 559A-559A.
Wyatt, Brooke, et al. “HCV CURE LEADS TO IMPROVEMENTS IN TYPE 2 DIABETES.” HEPATOLOGY, vol. 72, 2020, pp. 559A-559A.
Wyatt B, Abraham SV, Dinani A, Mageras A, Miller M, Harty AL, Perumalswami PV, Vandromme M, Branch AD. HCV CURE LEADS TO IMPROVEMENTS IN TYPE 2 DIABETES. HEPATOLOGY. 2020. p. 559A-559A.
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
November 2020
Volume
72
Start / End Page
559A / 559A
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences